(AFYA) Afya - Ratings and Ratios
Exchange: NASDAQ • Country: Brazil • Currency: USD • Type: Common Stock • ISIN: KYG011251066
AFYA: Medical Education, Online Courses, Health Services, Software Solutions
Afya Ltd (NASDAQ:AFYA) stands as a prominent medical education group in Brazil, operating through three key segments: Undergrad, Continuing Education, and Digital Services. Their offerings encompass a wide array of educational products and services, including medical schools, residency preparatory courses, and graduate programs, catering to lifelong medical learners both within their network and at third-party institutions.
Their digital health services are a cornerstone, featuring a subscription-based mobile app and website that assist health professionals and students with clinical decision-making. These tools include medical calculators, updated content, and resources for prescriptions and clinical procedures, enhancing practical efficiency.
Expanding beyond traditional medical fields, Afya provides courses in diverse areas such as business administration, accounting, and engineering. Their digital solutions include iClinic practice management software and an online medical education platform, offering comprehensive support for both education and clinical practice.
Financially, Afya presents a market cap of $1.599 billion, with a P/E ratio of 15.93 and a forward P/E of 11.36, indicating potential for growth. Their P/S ratio of 0.50 reflects a robust revenue generation capacity, positioning them as a significant player in the education and digital health sectors.
Additional Sources for AFYA Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AFYA Stock Overview
Market Cap in USD | 1,467m |
Sector | Consumer Defensive |
Industry | Education & Training Services |
GiC Sub-Industry | Education Services |
IPO / Inception | 2019-07-19 |
AFYA Stock Ratings
Growth 5y | -21.6% |
Fundamental | 79.3% |
Dividend | 0.0% |
Rel. Strength Industry | -19.4 |
Analysts | 3.33/5 |
Fair Price Momentum | 16.62 USD |
Fair Price DCF | 439.84 USD |
AFYA Dividends
No Dividends PaidAFYA Growth Ratios
Growth Correlation 3m | 77.3% |
Growth Correlation 12m | -54.7% |
Growth Correlation 5y | -39.9% |
CAGR 5y | 0.92% |
CAGR/Max DD 5y | 0.01 |
Sharpe Ratio 12m | -0.12 |
Alpha | -21.13 |
Beta | 0.89 |
Volatility | 37.08% |
Current Volume | 208.5k |
Average Volume 20d | 100.2k |
As of March 16, 2025, the stock is trading at USD 18.03 with a total of 208,454 shares traded.
Over the past week, the price has changed by +5.25%, over one month by +1.98%, over three months by +17.61% and over the past year by -11.14%.
Yes, based on ValueRay Fundamental Analyses, Afya (NASDAQ:AFYA) is currently (March 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 79.32 and therefor a positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AFYA as of March 2025 is 16.62. This means that AFYA is currently overvalued and has a potential downside of -7.82%.
Afya has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AFYA.
- Strong Buy: 1
- Buy: 2
- Hold: 5
- Sell: 1
- Strong Sell: 0
According to ValueRays Forecast Model, AFYA Afya will be worth about 18.2 in March 2026. The stock is currently trading at 18.03. This means that the stock has a potential upside of +1.05%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 19 | 5.3% |
Analysts Target Price | 20 | 10.9% |
ValueRay Target Price | 18.2 | 1.1% |